![]() |
|
|||||
| Qualifications |
|
SUNY at Albany, B.S. (Biology), 1977
|
| Research Interests |
| Control of Gene Expression, Development, Immunoglobulins, and Oncogenesis. |
| Research Summary |
| The Atchison laboratory is interested in determining the molecular mechanisms responsible for transcriptional regulation and the control of differentiation. To pursue these studies, we explore the functions of a number of transcription factors that regulate immunoglobulin gene expression and that play important roles in lineage differentiation, embryonic development, or oncogenesis. These transcription factors include PU.1, IRF-4, E47, Pax-5, YY1, and Oct4. Each of these proteins is crucial for either proper B cell, myeloid or erythroid development, or for embryonic development. Some may also be involved in the process of somatic hypermutation of rearranged immunoglobulin genes. We pursue our studies by biochemical, molecular biological, genetic, and developmental approaches using a variety of experimental systems including cell lines representing defined stages of B cell development, multipotential tumor lines, transgenic animals, and chimeric mice. In addition to the above mammalian systems, some projects utilize Drosophila systems. |
| Selected Publications |
Bai, Y., Srinivasan, L., Perkins, L., and Atchison, M.L. Protein acetylation regulates both PU.1 transactivation and Igκ 3’ enhancer activity. J. Immunol. 175:5160-5169 (2005). McDevit, D.C., Perkins, L., Atchison, M.L. , and Nikolajczyk, B.S. The Igκ 3’ enhancer is activated by gradients of chromatin accessibility and protein association. J. Immunol. 174: 2834-2842 (2005). Srinivasan, L. and Atchison, M.L. YY1 DNA Binding and PcG Recruitment Requires CtBP. Genes Dev. 18: 2596-2601 (2004). Joo, M., Park, G.Y., Wright, J.G., Blackwell, T.S., Atchison, M. and Christman, J.W. Transcriptional regulation of cyclooxygenase-2 gene in macrophages by PU.1. J. Biol. Chem. 279:6658-6665 (2004). Atchison, L., Ghias, A., Wilkinson, F., Bonini, N., and Atchison, M.L. Transcription factor YY1 functions as a PcG in vivo. EMBO J. 22:1347-1358 (2003). Yu, D., Allman, D., Goldschmidt, M.H., Atchison, M.L. , Monroe, J.G., and Thomas-Tikhonenko, A. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway. Blood101:1950-1955(2003). |
Lab personnelMichael Atchison, Ph.D. P.I. Kyoungsook Park, Ph.D. Visiting Scientist Frank Wilkinson, Ph.D. Post-doc Lakshmi Srinivasan, Ph.D. Post-doc Fang Wei, Ph.D Post-doc Christina Zaprazna, M.S. Graduate Student Suchita Hodawadekar, B.S. Research Specialist Aisha Ghias, Research Specialist Brandan Youngman, Undergraduate student Kathleen O’Roark, Undergraduate student |
